REFERENCE · RECOVERY TECHNIQUE
Treadmill and Body-Weight-Supported Walking for Functional Gait Disorder
Most likely fit: Over-ground walking repeatedly stops, step continuity improves when the surface moves beneath the feet, or fall protection and partial unloading are needed to practise alternating steps safely. [Clinical consensus; direct device-specific evidence in functional gait disorder is limited]
Not the same as: Placing anyone with functional gait symptoms on a treadmill, treating a harness as complete fall prevention, or continuing belt movement when foot clearance, awareness, cardiopulmonary response or emergency stopping is unsafe.
For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources
—
For the Person With FND
What the equipment can change
A treadmill supplies a continuous moving surface and a predictable direction. This can sometimes help alternating steps continue without restarting each one. A body-weight-support system uses an overhead or frame-mounted harness. Depending on its setup, it may reduce how much weight passes through the legs, arrest a fall, or do both.
The treadmill and harness are tools, not treatments by themselves. The useful part might be continuous rhythm, safer repetition, partial unloading or confidence to practise a step. That feature still has to transfer to over-ground walking.
Anatomy in everyday language
The belt moves backward relative to the body, so each foot must accept weight, allow the body to pass over it and then enter swing for the next contact. The hips, knees and ankles repeat stance and swing while the trunk stays over the changing base of support.
Partial unloading reduces some vertical force through the feet and legs, but it also changes normal sensory information and muscle demand. A fall-arrest harness may not unload the legs at all. In plain language, clinicians must know whether the equipment is carrying part of you, merely catching you, or both.
What a session may look like
The team fits the harness, explains the emergency stop and starts with the belt still. You may first stand, shift weight or step while holding the rails. The belt begins at a very low selected speed with staff guarding the feet, trunk and controls as required. Short bouts are transferred to over-ground steps with the usual aid.
This is not home treadmill advice. Stop for foot catching, harness pain, skin pressure, breathlessness outside the agreed range, chest pain, faintness, altered awareness, uncontrolled leaning or inability to use the stop procedure.
For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources
—
For Family, Friends, and Other Supporters
Do not operate the treadmill, change speed, alter harness unloading or provide manual stepping assistance unless you are trained and authorized within the clinical setting. Stay clear of the belt and equipment path.
At home, support the over-ground practice specifically prescribed after the session. A person walking in a harness does not establish that an ordinary home treadmill is safe.
For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources
—
For Clinicians and the Care Team
Selection, equipment and staffing
Define whether the primary purpose is rhythmic belt-driven stepping, partial weight support, fall arrest, endurance dosing or assessment of a transformation. Review cardiovascular and respiratory stability, orthostatic intolerance, seizure or altered-awareness risk, skin integrity, pain, joint restrictions, osteoporosis, body-size limits and ability to follow emergency instructions.
Follow the manufacturer’s fitting, inspection, staffing and weight-limit requirements. Distinguish percentage body-weight unloading from a slack fall-arrest harness. Establish emergency lowering and equipment-failure procedures; the emergency stop must be immediately controlled by trained staff.
Explicit procedure
- Record over-ground gait, aid use, assistance, distance and the feature targeted.
- Inspect the device and fit the harness, checking groin, trunk and shoulder pressure and all attachment points.
- Orient the person with the belt stationary; rehearse stopping and staff roles.
- Establish stance, hand support and weight shift before belt movement.
- Begin at the lowest clinically useful speed and unloading level with required foot and trunk guarding.
- Use one cue for alternating steps, destination or rhythm; avoid multiple simultaneous corrections.
- Limit the first bout and check symptoms, skin, blood pressure or cardiopulmonary response when indicated.
- Adjust one variable at a time: speed, unloading, hand support, cueing or duration.
- Practise over-ground walking with the usual aid during the same session to test carryover.
- Stop for repeated toe catch, uncontrolled knee collapse, harness intolerance, presyncope, chest symptoms, altered awareness or loss of emergency control.
Outcomes and evidence boundary
Measure number and duration of bouts, assistance, unloading, speed, step continuity, foot clearance, over-ground carryover, symptoms and delayed response. Device parameters should be recorded well enough for another clinician to reproduce or safely reject the setup.
Specialist consensus includes treadmill and body-weight-supported approaches among possible gait strategies. Broader functional-motor trials do not establish that the device itself causes benefit or identify a functional-gait subgroup response. [1][2]
For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources
—
Research and Sources
| Citation | Full citation |
|---|---|
| [1] | Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. Journal of Neurology, Neurosurgery & Psychiatry. 2015;86(10):1113–1119. FND-CIT-0028. https://doi.org/10.1136/jnnp-2014-309255 |
| [2] | Nielsen G, Stone J, Lee TC, et al. Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial. The Lancet Neurology. 2024;23(7):675–686. FND-CIT-0029. https://doi.org/10.1016/S1474-4422(24)00135-2 |
Detailed technique page created September 12, 2026 · Clinical and accessibility review pending
For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources
—